Dominique Leveque
Avenue Molière
Strasbourg, 67000, France
Strasbourg, 67000, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 55 publications
The importance and utility of post market drug safety monitoring in cancer therapy.
Journal: Expert opinion on drug safety
Published: October 16, 2025
Oral anticancer agents as generators of relevant pharmacokinetic interactions: An update.
Journal: Bulletin du cancer
Published: August 01, 2025
Improving the Dosing Schedules of Targeted Anticancer Agents.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: March 10, 2025
Discrepancy in withdrawn accelerated approvals of anticancer agents in the United States (US) and Europe: Approval does not mean access.
Journal: Bulletin du cancer
Published: June 15, 2024
Dispensation for access to novel anticancer agents in France.
Journal: The Lancet. Oncology
Published: April 18, 2023
Oral anticancer agents as generators of relevant pharmacokinetic interactions.
Journal: Bulletin du cancer
Published: December 28, 2022
Clinical Pharmacokinetics and Pharmacodynamics of Dasatinib.
Journal: Clinical pharmacokinetics
Published: March 01, 2020
Intravenous and subcutaneous administration of trastuzumab in a patient on peritoneal dialysis.
Journal: British journal of clinical pharmacology
Published: October 20, 2019
Enzalutamide in Metastatic Prostate Cancer.
Journal: The New England journal of medicine
Published: October 10, 2019
The role of therapeutic drug monitoring in the management of safety of anticancer agents: a focus on 3 cytotoxics.
Journal: Expert opinion on drug safety
Published: September 04, 2019
Last Updated: 09/26/2026